Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Minasian

Showing results (161-170 of 174) with videos related to

Pageof 18
Sort By:
JNCI Cancer Spectrum|May 30, 2024
Effects of vitamin D supplementation on a deep learning-based mammographic evaluation in SWOG S0812Julia E McGuinness, Garnet L Anderson, Simukayi Mutasa, et al.
Journal of the National Cancer Institute|October 1, 2014
Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)Ethan Basch, Bryce B Reeve, Sandra A Mitchell, et al.
JAMA Oncology|February 17, 2017
Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical TrialsEthan Basch, Amylou C Dueck, Lauren J Rogak, et al.
Cancer Treatment Reviews|May 21, 2019
Improving attribution of adverse events in oncology clinical trialsGoldy C George, Pedro C Barata, Alicyn Campbell, et al.
Journal of the National Cancer Institute|October 30, 2018
Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230Halle C F Moore, Joseph M Unger, Kelly-Anne Phillips, et al.
The Lancet. Oncology|October 5, 2014
Prevention and early detection of prostate cancerJack Cuzick, Mangesh A Thorat, Gerald Andriole, et al.
JAMA Oncology|August 14, 2015
Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Amylou C Dueck, Tito R Mendoza, Sandra A Mitchell, et al.
Journal of the National Cancer Institute|January 20, 2005
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Scott M Lippman, Phyllis J Goodman, Eric A Klein, et al.
Journal of the National Cancer Institute|October 15, 2010
Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translationAndrew N Freedman, Leah B Sansbury, William D Figg, et al.
Scientific Data|January 12, 2023
GWAS Explorer: an open-source tool to explore, visualize, and access GWAS summary statistics in the PLCO AtlasMitchell J Machiela, Wen-Yi Huang, Wendy Wong, et al.
Pageof 18

Showing results (161-170 of 174) with videos related to

Sort By:
Pageof 18
JNCI Cancer Spectrum|May 30, 2024
Effects of vitamin D supplementation on a deep learning-based mammographic evaluation in SWOG S0812Julia E McGuinness, Garnet L Anderson, Simukayi Mutasa, et al.
Journal of the National Cancer Institute|October 1, 2014
Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)Ethan Basch, Bryce B Reeve, Sandra A Mitchell, et al.
JAMA Oncology|February 17, 2017
Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical TrialsEthan Basch, Amylou C Dueck, Lauren J Rogak, et al.
Cancer Treatment Reviews|May 21, 2019
Improving attribution of adverse events in oncology clinical trialsGoldy C George, Pedro C Barata, Alicyn Campbell, et al.
Journal of the National Cancer Institute|October 30, 2018
Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230Halle C F Moore, Joseph M Unger, Kelly-Anne Phillips, et al.
The Lancet. Oncology|October 5, 2014
Prevention and early detection of prostate cancerJack Cuzick, Mangesh A Thorat, Gerald Andriole, et al.
JAMA Oncology|August 14, 2015
Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Amylou C Dueck, Tito R Mendoza, Sandra A Mitchell, et al.
Journal of the National Cancer Institute|January 20, 2005
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Scott M Lippman, Phyllis J Goodman, Eric A Klein, et al.
Journal of the National Cancer Institute|October 15, 2010
Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translationAndrew N Freedman, Leah B Sansbury, William D Figg, et al.
Scientific Data|January 12, 2023
GWAS Explorer: an open-source tool to explore, visualize, and access GWAS summary statistics in the PLCO AtlasMitchell J Machiela, Wen-Yi Huang, Wendy Wong, et al.
Pageof 18